Importance The increasing cost of prescription drugs in the United States has become a
source of concern for patients, prescribers, payers, and policy makers. Objectives To review …

Background Direct out-of-pocket payments (OOP) are among the most important financing
mechanisms in many health systems, especially in develo** countries, adversely affecting …

Purpose The number of novel oral anticancer agents is increasing, but financial barriers may
limit access. We examined associations between out-of-pocket (OOP) costs and reduced …

Objectives To assess the effects of costs on access to medicines in 11 developed countries
offering different levels of prescription drug coverage for their populations. Design Cross …

Health policy in the United States has been shaped by the political, socioeconomic, and
ideological environment, with important roles played by public and private actors, as well as …

BACKGROUND: US health plans are adopting benefit designs that shift greater financial
burden to patients through higher deductibles, additional copay tiers, and coinsurance. Prior …

BACKGROUND: Disease-modifying therapies (DMTs) are indicated to reduce relapse rates
and slow disease progression for relapsing-remitting multiple sclerosis (MS) patients when …

Background. More than 1 in 4 Americans report difficulty paying medical bills. Cost-reducing
strategies discussed during outpatient physician visits remain poorly characterized …

Importance List prices set by manufacturers for brand-name prescription drugs in the US
have been increasing faster than inflation, although confidential manufacturer rebates offset …

Objective To determine out-of-pocket costs for neurologic medications in 5 common
neurologic diseases. Methods Utilizing a large, privately insured, health care claims …